Choose one of the below
It's a year since I reported on the statusof the LeoDOR study so I think it's morethan time to bring readers up to date with our progress.Read more..
Gozeler MS, Ekinci Akdemir FN, Yildirim S, Sahin A, Eser G, Askin S
Int J Pediatr Otorhinolaryngol
Yang F, Zhao LN, Sun Y, Chen Z
J Int Med Res
Hessel EA 2nd
J Cardiothorac Vasc Anesth
Beiras-Fernandez A, Kornberger A, Oberhoffer M, Kur F, Weis M, Vahl CF, Weis F
Bunte S, Lill T, Falk M, Stroethoff M, Raupach A, Mathes A, Heinen A, Hollmann MW, Huhn R
J Clin Med
Abdelrahman AM, Al Suleimani Y, Shalaby A, Ashique M, Manoj P, Al-Saadi H, Ali BH
Important information SIMDAX is indicated for the short-term treatment of acutely decompensated severe chronic heart failure (ADHF) in situations where conventional therapy is not sufficient, and in cases where inotropic support is considered appropriate. Read more..
To download the Simdax SPC in pdf format, click here.
Read the SPC
Find out where Simdax is available.
Product Monograph - Updated 2018
Summary of product characteristics
General information about SIMDAX
Information about dosing and other guidance for use
SIMDAX in Acute Heart Failure
SIMDAX in Intensive Care Unit
SIMDAX in Operating Theater
SIMDAX in Advanced Heart Failure